Grants Search Results

Pleuropulmonary blastoma (PPB) is a rare lung cancer of young children. Inherited genetic mutations have been recently identified in a gene known as DICER1 that predisposes children to developing PPB as well as other childhood tumors arising in the muscle, brain, ovary and kidneys. This laboratory research is complimented by the first-ever prospective clinical study of PPB therapy that determines treatments with optimal effectiveness for PPB patients. The goal of these collaborative studies is to identify the critical deregulated signals that promote cancer development in order to develop novel interventions to improve outcomes for children with PPB and the related pediatric cancers. Funds administered by Cincinnati Children's Hospital Medical Center.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Pediatric Blood & Marrow Transplant Consortium. For a description of this project, "Innovative Pilot Trials in Pediatric HSCT for Malignancies-PBMTC Core Grant," see the consortium grant made to the lead institution: the National Marrow Donor Program, Minneapolis, MN.